DYRK2 controls a key regulatory network in chronic myeloid leukemia stem cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2092-6413
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
DYRK2 controls a key regulatory network in chronic myeloid leukemia stem cells ; volume:52 ; number:10 ; day:16 ; month:10 ; year:2020 ; pages:1663-1672 ; date:10.2020
Experimental & molecular medicine ; 52, Heft 10 (16.10.2020), 1663-1672, 10.2020
- Urheber
-
Park, Chun Shik
Lacorazza, H. Daniel
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s12276-020-00515-5
- URN
-
urn:nbn:de:101:1-2020122120074951558380
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:38 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Park, Chun Shik
- Lacorazza, H. Daniel
- SpringerLink (Online service)
Ähnliche Objekte (12)
The splicing factor RBM25 controls MYC activity in acute myeloid leukemia
Protein arginine methyltransferase 2 controls inflammatory signaling in acute myeloid leukemia
Midostaurin reduces Regulatory T cells markers in Acute Myeloid Leukemia
Metabolic stress controls mutant p53 R248Q stability in acute myeloid leukemia cells
Hyperfunction of CD4 CD25 regulatory T cells in de novo acute myeloid leukemia
Epigenetic alterations affecting hematopoietic regulatory networks as drivers of mixed myeloid/lymphoid leukemia
Transcriptomic analysis delineates potential regulatory network as therapeutic alternatives in chronic myeloid leukemia
Pregnancy with acute myeloid leukemia
Chronic myeloid leukemia in India
Circular RNA regulatory network reveals cell–cell crosstalk in acute myeloid leukemia extramedullary infiltration
Role of regulatory T cells in acute myeloid leukemia patients undergoing relapse-preventive immunotherapy
Immunogenicity of leukemia stem cells in acute myeloid leukemia
The splicing factor RBM25 controls MYC activity in acute myeloid leukemia
Protein arginine methyltransferase 2 controls inflammatory signaling in acute myeloid leukemia
Midostaurin reduces Regulatory T cells markers in Acute Myeloid Leukemia
Metabolic stress controls mutant p53 R248Q stability in acute myeloid leukemia cells
Hyperfunction of CD4 CD25 regulatory T cells in de novo acute myeloid leukemia
Epigenetic alterations affecting hematopoietic regulatory networks as drivers of mixed myeloid/lymphoid leukemia
Transcriptomic analysis delineates potential regulatory network as therapeutic alternatives in chronic myeloid leukemia
Pregnancy with acute myeloid leukemia
Chronic myeloid leukemia in India
Circular RNA regulatory network reveals cell–cell crosstalk in acute myeloid leukemia extramedullary infiltration
Role of regulatory T cells in acute myeloid leukemia patients undergoing relapse-preventive immunotherapy
Immunogenicity of leukemia stem cells in acute myeloid leukemia
The splicing factor RBM25 controls MYC activity in acute myeloid leukemia
Protein arginine methyltransferase 2 controls inflammatory signaling in acute myeloid leukemia
Midostaurin reduces Regulatory T cells markers in Acute Myeloid Leukemia
Metabolic stress controls mutant p53 R248Q stability in acute myeloid leukemia cells
Hyperfunction of CD4 CD25 regulatory T cells in de novo acute myeloid leukemia
Epigenetic alterations affecting hematopoietic regulatory networks as drivers of mixed myeloid/lymphoid leukemia
Transcriptomic analysis delineates potential regulatory network as therapeutic alternatives in chronic myeloid leukemia
Pregnancy with acute myeloid leukemia
Chronic myeloid leukemia in India
Circular RNA regulatory network reveals cell–cell crosstalk in acute myeloid leukemia extramedullary infiltration
Role of regulatory T cells in acute myeloid leukemia patients undergoing relapse-preventive immunotherapy